Alcidion

Alcidion Alcidion provides smarter solutions for clinicians. Alcidion provides active intelligence and decision support software for high performance healthcare.

With our FHIR-events platform, Miya Precision, we assist healthcare organisations in building interoperable digital ecosystems that liberate data to enhance patient outcomes. Alcidion is an innovative health informatics company that specializes in clinical products that improve productivity, safety and efficiency. By making clinicians more efficient, eliminating key clinical risks, tracking patient progress through journeys within and between healthcare facilities and making recommendations about patient care to the care team based on complex analysis of the clinical and administrative context for each patient, the patient flow, patient safety and organisational efficiency can all be improved and key critical risks eliminated. Alcidion has created the Miya Platform, which uses a Decision Support Engine (DSE) to actively monitor electronic data feeds to detect emerging risk to patients and to the organization. Miya can provide guidance to the right people to mitigate risk before harm occurs.

Join Alcidion Chief Product Officer, Kaye Hocking, for an exclusive investor event on Thursday 29th October in Melbourne...
01/10/2026

Join Alcidion Chief Product Officer, Kaye Hocking, for an exclusive investor event on Thursday 29th October in Melbourne.

The market is increasingly distinguishing between companies merely exposed to AI and those with the data, workflow depth, distribution and governance to apply it responsibly. At the event, Alcidion (ASX: ALC) will be presenting alongside Cogstate (ASX: CGS) and Netwealth (ASX: NWL) on how we offer investors exposure to highly regulated, intelligent infrastructure in critical markets.

These are not standalone AI propositions. They are established platforms operating in high-trust, regulated and reputation-sensitive settings—clinical trials, hospitals and financial advice, where reliability, security, compliance and customer outcomes are non-negotiable. Each is positioned to use AI to improve insight, productivity and user experience while reinforcing the value of its core platform.

šŸ“…Intelligent Infrastructure: AI-Ready Platforms in Critical Markets
Thursday, 29th October 2026
4:30 PM – 7:00 PM
Drinks and canapƩs served

šŸ“Hosted at Investor Hub
452 Flinders Lane, Melbourne

Places limited - register here: https://ap1.hubs.ly/H01pRq80

An investor briefing with three ASX‑listed platforms embedded in healthcare, clinical research and adviser‑led wealth management, where reliability, compliance and trust decide who gets to own the AI layer.

Optimising patient flow is one of the key levers hospitals can pull to improve capacity without additional beds. But how...
29/09/2026

Optimising patient flow is one of the key levers hospitals can pull to improve capacity without additional beds. But how can health leaders actually do that?

The Alcidion team recently combined 25 years’ worth of healthcare informatics experience to write the handbook for hospital leaders navigating this question.

The authors of FLOW: A Handbook to Creating the Right Conditions for Patient Flow, Dr Paul Deffley and Nick White joined Peter Birch from Talking HealthTech to talk about the release, including:
Ā· why this was the time to write it
Ā· who can benefit
Ā· the impact of system-wide visibility
Ā· metrics for measuring success with patient flow initiatives
Ā· and more

šŸŽ™ļøCheck out the interview here: https://ap1.hubs.ly/H01pnX70

šŸ“– The handbook is available to clinicians, leaders and managers working for acute care systems in Australia, New Zealand, the UK and Canada. Looking to grab a copy? Reach out to the Alcidion team at: https://ap1.hubs.ly/H01pnX90

Discover practical strategies for improving patient flow in hospitals with Nick White and Dr. Paul Deffley from Alcidion on Talking HealthTech.

Patient flow just became a national priority. The 2026-31 Australian National Health Reform Strategy lists improved pati...
23/09/2026

Patient flow just became a national priority.

The 2026-31 Australian National Health Reform Strategy lists improved patient flow and integration between care systems as the first national priority under Appropriate Care.

The Strategy names growing demand and rising complexity of care among the system's core challenges, and puts numbers against them: 38% of Australians live with multimorbidity, EDs saw 9.1 million presentations in 2024-25 and hospitals manage 34,500 hospitalisations a day.

Building more beds doesn't solve this. It's slow, expensive, and new beds still need staff at a time when workforce shortages are one of the system's core challenges.

That leaves one variable health systems can still move: how well they use the capacity they already have.

The UK has landed on the same conclusion. The National Audit Office recently recommended more consistent use of end-to-end hospital flow management tools to ease pressure on NHS emergency departments.

Two health systems, different funding models, different structures, the same lever, the same year.

Hospitals leading digital adoption have already seen the benefits of system-wide visibility of flow, including lower length of stay, smoother capacity management and released time to care.

Now this approach is a national response to demand that can't be met by building more.

šŸ“„ Read the Australian National Health Reform Strategy: https://ap1.hubs.ly/H01nTCj0

šŸ“„ Read the UK National Audit Office report: https://ap1.hubs.ly/H01nTBz0

More consistent use of end-to-end hospital flow management tools is now part of a National Audit Office (NAO) recommenda...
10/09/2026

More consistent use of end-to-end hospital flow management tools is now part of a National Audit Office (NAO) recommendation for NHS trusts.

The report is clear about the need. Since 2021 hospital doctor numbers are up 34% and MRI and CT scans are up by around half, while attendances waiting over 4 hours rose from 5 to 7 million between 2021-22 and 2025-26. Despite more resources in the ED - pressure and wait times persist.

The NAO report points beyond the ED to inpatient bed availability and delayed discharge as key modifiable factors behind poor patient flow, with delayed discharge accounting for 14.7% of all bed days in April 2026 alone.

Care teams cannot manage what they cannot see, and the NAO found there is no national picture of how patients move through a hospital after admission.

94% of NHS acute trusts now have an EPR in place (Digital Health, 2025). But digitising a patient record does not digitise patient flow. The report also states that not every trust with an EPR is using it to track flow, and in our experience this challenge is common, as many EPRs were not designed to manage the challenges with flow.

That is where a real-time patient flow platform comes in, and this is what the NAO is calling for. Miya Precision brings patient status, clinical history, bed availability and discharge blockers into a single view for the whole organisation, working with existing EPRs and other systems already in place to surface the information needed.

Trusts do not need to wait for a national picture to build their own and start acting on what it shows.
You can find the report here: https://ap1.hubs.ly/H01mvT_0
Read more about the NAO report: https://ap1.hubs.ly/H01mvV00

This report looks at how well patients flow through A&E into the wider hospital in England and at the support NHSE provides.

A packed agenda awaits us this week at EPR Scotland. šŸ„ The Alcidion team will be discussing how health boards can:- Buil...
07/09/2026

A packed agenda awaits us this week at EPR Scotland. šŸ„

The Alcidion team will be discussing how health boards can:
- Build on existing digital investments rather than starting again
- Connect information across systems and care settings using open standards and interoperability
- Give clinicians timely access to information at the point of care
- Introduce new capabilities progressively, supporting transformation at a pace that works for each organisation
- Make better use of real-time data to support clinical and operational decision-making

We also look forward to seeing CCIO Tracy McClelland take the stage alongside CNIO Elizabeth Klein and Senior Programme Manager Nia-maria Quinlan from North Cumbria Integrated Care NHS Foundation Trust, as well as Alcidion UK Head Of Delivery Operations Darren McTaggart.

āž”ļøCome meet the Alcidion team on the day, or reach out to us at https://ap1.hubs.ly/H01lM2x0

While AI continues to dominate conversations about the future of healthcare, another emerging technology has quietly bee...
31/08/2026

While AI continues to dominate conversations about the future of healthcare, another emerging technology has quietly been building momentum: quantum.

In her latest article, Alcidion Chief Clinical Information Officer Tracy McClelland explores why the UK's opportunity in quantum extends well beyond scientific innovation, and what healthcare organisations need to do now to prepare for its real-world impact.

As Tracy notes:

"The NHS holds one of the richest longitudinal health datasets in the world. That is a genuine quantum-era asset. But data richness is not the same as data readiness."

The UK's quantum potential will be shaped not just by breakthrough technologies, but by the foundations that enable them, including data quality, interoperability and organisational readiness.

Read the full article: https://ap1.hubs.ly/H01kW670

By Tracy McClelland, Chief Clinical Information Officer, Alcidion This article originally featured on the Healthcare Engagement Society Community. I am a nurse and CCIO, not a quantum scientist. I want to be clear about that upfront, because it shapes exactly what I think the UK’s most important q...

⚔The focus was on AI at last month’s ANDHealth Unfiltered conference, where Kate Quirke, Alcidion Group Managing Directo...
18/08/2026

⚔The focus was on AI at last month’s ANDHealth Unfiltered conference, where Kate Quirke, Alcidion Group Managing Director and CEO, presented a keynote on the realities of building, certifying and deploying in healthcare.

This was a practical look at what it takes to move a capability from pilot into production, and then to scale it across international health systems.
šŸ“ Kate’s key takeaways:
- Data readiness comes before AI readiness
- Successful projects begin with the problem, not the AI
- AI tools must fit seamlessly into existing clinical workflows. Extra logins or duplicated work will halt adoption before it even gets off the ground.

Kate also joined the panel 'Your AI Can Be Copied. Your Moat Cannot.' to explore where durable value sits once the technology itself is no longer the differentiator.

Missed it? Check out the key insights from across the day here: https://ap1.hubs.ly/H01hTGf0

šŸ„ Uncomplicated diverticulitis puts more than 19,000 Australians in a hospital bed each year. New trial evidence suggest...
11/08/2026

šŸ„ Uncomplicated diverticulitis puts more than 19,000 Australians in a hospital bed each year. New trial evidence suggests many of them don't need one.

A clinical trial published in the ANZ Journal of Surgery in June found that selected patients with acute uncomplicated diverticulitis were able to be safely managed at home, using remote patient monitoring technology underpinned by the Miya Precision platform.

The trial found that 93% of the selected patients completed treatment without crossing over to inpatient care, with zero major complications. Patient experience was markedly better than conventional admission, with 88% rating their care as excellent compared with 40% of those admitted, and 88% reporting their healthcare needs were always met compared with 47%.

The pathway was delivered through Sydney Virtual Hospital, formerly RPA Virtual, which has supported virtual care for over 85,000 patients since 2020.

We've published a whitepaper looking at what these findings mean for health systems planning virtual ward and Hospital-in-the-Home (HiTH) pathways.

With advances in technology, more and more acute conditions are able to be managed at home safely. In order to successfully scale the pathways healthcare systems need to invest in the supporting infrastructure: what platform is used to enable a virtual pathway to make it safe, governable and scalable.

Remote monitoring without escalation logic is data without action. Video consultation without EMR integration is contact without clinical context.

For anyone responsible for inpatient capacity, admission avoidance or virtual care delivery, the whitepaper sets out the five conditions the trial demonstrates are needed to do this safely.

āž”ļø Read it here: https://ap1.hubs.ly/H01fZq-0

Sydney Local Health District Miranda Shaw

Findings from the landmark iCAD clinical trial, and what they mean for virtual care at scale In June 2026, a landmark randomised clinical trial published in the ANZ Journal of Surgery demonstrated something that challenges a fundamental assumption of acute surgical care. Evidence suggests that for p...

HIC2026: Innovation to Impact will see Chief Product Officer Kaye Hocking present a brief tour through the evolution of ...
31/07/2026

HIC2026: Innovation to Impact will see Chief Product Officer Kaye Hocking present a brief tour through the evolution of digital Virtual Care.

Acute clinical care is no longer tied to the hospital bed – and with that change we are seeing measurable benefit to patients, clinicians and health systems.

On Monday Kaye will walk through some of these improvements delivered at Sydney LHD’s Sydney Virtual Hospital and Goulburn Valley Health with Miya Virtual Care, from supporting patients through COVID-19 to remote care for regional Australian mums to scaling care beyond the walls of the hospital.

šŸ—“ļøMonday, August 3, 2026
ā²ļø2:30 PM - 2:45 PM
šŸ“Darling Harbour Theatre

If you’re attending HIC 2026 in Sydney, be sure to join Kaye's session or catch the Alcidion team at booth number 3.

Address

Melbourne, VIC

Alerts

Be the first to know and let us send you an email when Alcidion posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share